Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Rev Med Suisse ; 4(154): 1056-61, 2008 Apr 23.
Article in French | MEDLINE | ID: mdl-18557535

ABSTRACT

Hemolytic uremic syndrome (HUS) in children is classically associated with diarrheas related to the production of a shiga-toxin. HUS occurs among oncologic patients, in relation with the cancer itself, or as a complication of the cytostatic treatment. The physician should be familiar with the triad of HUS (microangiopathic hemolytic anemia, thrombocytopenia and renal failure) and search actively for this pathology in oncologic patient. The treatment is essentially empirical. It includes plasma exchanges, control of blood pressure, hydro-electrolytic balance control with dialysis, if necessary. Blood transfusion should be avoided. Potential mortal complications associated with HUS can be prevented by a rapid diagnosis and a prompt initiation of adequate therapy.


Subject(s)
Antimetabolites, Antineoplastic/adverse effects , Deoxycytidine/analogs & derivatives , Hemolytic-Uremic Syndrome/chemically induced , Deoxycytidine/adverse effects , Female , Humans , Middle Aged , Gemcitabine
2.
Rev Med Suisse ; 2(75): 1861-6, 2006 Aug 09.
Article in French | MEDLINE | ID: mdl-16948423

ABSTRACT

Bone metastasis are very common in many cancers; metastatic bone disease is the most common cause of cancer pain and also of serious complications, which reduce the quality of life of these patients. Management of skeletal cancer involves a multimodality approach who include bisphosphonates, which in association with anti-tumour treatments reduce the apparition of new skeletal-related events (SRE) and prolong the delay to first SRE. They although reduce the pain of bone metastasis. All this facts do the quality of life better.


Subject(s)
Bone Density Conservation Agents/therapeutic use , Bone Neoplasms/drug therapy , Bone Neoplasms/secondary , Diphosphonates/therapeutic use , Humans
3.
Klin Monbl Augenheilkd ; 212(5): 416-7, 1998 May.
Article in German | MEDLINE | ID: mdl-9677597

ABSTRACT

The authors report on a 46 year-old patient who presented with a chronic unilateral vitritis. A diagnosis of cerebral lymphoma was made 4 years earlier and a maxillary sinus recurrence was treated with chemotherapy and radiotherapy. A vitrectomy was performed and the level of Interleukin-10, a lymphoma cells growth factor, was found very high, giving a clue for the lymphomatous cause of the vitritis.


Subject(s)
Brain Neoplasms/immunology , Interleukin-10/metabolism , Lymphoma, B-Cell/immunology , Maxillary Sinus Neoplasms/immunology , Vitreous Body , Brain Neoplasms/pathology , Brain Neoplasms/therapy , Combined Modality Therapy , Follow-Up Studies , Humans , Lymphoma, B-Cell/pathology , Lymphoma, B-Cell/therapy , Male , Maxillary Sinus Neoplasms/pathology , Maxillary Sinus Neoplasms/therapy , Middle Aged , Neoplasm Recurrence, Local/immunology , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/therapy , Vitreous Body/immunology , Vitreous Body/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...